CARMEN MARTI: Open Payments
NPI 1598317497 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$924 in 47 payments from 12 companies in 2025. Trend: 2023 $1,444 · 2024 $576 · 2025 $924
Food & beverage: $924
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 7 | $178 |
| ABBVIE INC. | 15 | $159 |
| Almatica Pharma LLC | 4 | $111 |
| Otsuka America Pharmaceutical, Inc. | 5 | $108 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $74 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Lundbeck LLC | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
Products named: COBENFY, VRAYLAR, REXULTI, LOREEV XR, CAPLYTA, TRINTELLIX, Auvelity, FANAPT.
Industry payments across FL — which companies pay providers there.
